Funding · Company
Elucid Bioimaging Inc.
Boston, MABiotech & Pharma
Elucid Bioimaging Inc. of Boston, MA has disclosed $115M across 2 Form D offerings filed with the SEC between Nov 22, 2023 and Oct 22, 2025.
$115M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$36M
Form D · Oct 22, 2025 ↗
Q4 2025
· target $80M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001585931Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →